On the season three premiere of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Joël Brierre.
Joel Brierre is the Founder and CEO of the psychedelic wellness companies Kaivalya Kollectiv and Tandava Retreats, as well as co-founder of the 5-MeO-DMT education and training platform, F.I.V.E.. Joel has been a leader in the modern psychedelic movement, specifically in the realm of 5-MeO-DMT and the Bufo Alvarius toad, and has spent years helping to create safe and effective protocols around this molecule. With a passion for preparation and integration protocols, Joel and his team are involved in everything from clinical research and trainings to experiential retreats in Mexico and Jamaica.
Listen To All Episodes on YouTube
All season two episodes are now available on YouTube. Check out the Psychedelic Invest YouTube channel to listen to the entire season without a subscription.
More To Come for Season Three
We have a great season of another ten full episodes planned out for your enjoyment.
If you just found out about the podcast, we encourage you to check out the Psychedelic Invest Podcast page or subscribe to the show on your favorite audio platform to binge and catch up.
The Transcription is Coming Soon
Law & Regulation3 days ago
Psilocybin study for bipolar depression encourages more research
Psilocybin3 days ago
Magic Mushroom Edibles: Everything to Know, from Chocolates to Drops
LSD4 days ago
TECH HEAVY: The Magnificent Seven has suddenly become the Fantastic Four
Ketamine3 days ago
Prepping the psychedelic industry for MDMA approval
Psychedelics3 days ago
Psychedelics Effects on Sexual Functions
Law & Regulation2 days ago
Enveric sells cannabis patents to focus on psilocin candidates